Aegerion Pharmaceuticals Announces Additional Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Safety Profile
   
   
 

About Aegerion Pharmaceuticals

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of pharmaceuticals to treat cardiovascular (CV) and  metabolic disease.

 

   

 

   

        Copyright © Aegerion Pharmaceuticals, Inc. All rights reserved.

 

        Aegerion Pharmaceuticals, Inc. CenterPointe IV, 1140 Route 22 East, Suite 304, Bridgewater, NJ 08807 [T: 908-707-2100 F: 908-541-1155]

Overview
Mission and Values
Senior Management Team
Board of Directors
Scientific Advisory Board
About MTPI
About Technology 2
Publications
Current
Press Release Archive
Article Archive
Current
Press Release Archive
Article Archive